Further evidence of activity in conjunction with chemotherapy was seen in another advanced non-small cell lung cancer trial utilizing the TG4010 vaccine, a recombinant virus Vaccinia Ankara encoding both MUC1 and IL-2 [18]. The gene discussed is MUC1; the disease is non-small cell lung carcinoma.